# Viewpoint Round 2 — Editorial-Policy Reviewer Report

- **Round.** 2
- **Reviewer.** policy (Editorial-Policy Reviewer)
- **Date.** 2026-05-21
- **Manuscript commit.** `5fde2234b24b5c4e483bf5ba1ff72310f03e8694`
- **Target journal.** *The Lancet Digital Health*, article type Viewpoint
- **Model.** Anthropic Claude Opus 4.7 (1M-context variant), Claude Code dispatch

## Sources consulted (Round 2)

- `manuscript/main.tex` (v0.4, commit `5fde223`)
- `manuscript/references.bib`
- `manuscript/JOURNAL.md`
- `manuscript/cover-letter.md`
- `docs/ai-usage-disclosure.md`
- `docs/disclosure2-schema.json` (NEW since R1)
- `docs/ledger.md` (NEW since R1)
- `reviewer-logs/viewpoint-round-01/response-to-reviewers.md`
- `reviewer-logs/viewpoint-round-01/policy.md` (own R1 transcript)
- `reviewer-logs/viewpoint-round-01/methodology.md` (cross-check that the §5 "three forward-references" claim is now empirically true)

## Overall impression

The revision is strong. Of my twelve Round 1 comments, the one blocker (C1: policy mis-quotation) and all four high-severity comments (C2 symmetry, C3 Editorial Manager path, C4 equity, C5 self-undermining demonstration) are substantively addressed in the manuscript text and verifiable in the repository. The two newly committed artefacts (`docs/disclosure2-schema.json`, `docs/ledger.md` plus `scripts/regenerate_ledger.py`) close the most damaging artefact-drift finding from Round 1: the §5 claim that "the first round of reviewer-subagent critique caught three forward references to artefacts not yet committed" is now empirically anchored by the existence of those three files plus a methodology-reviewer transcript that explicitly flagged each one. The "we are produced under the standard" demonstration now reads honestly.

The Lancet policy paraphrase at §1 is now verbatim with quotation marks, separates AI-generated images and reviewer-AI use into their own sentence, and locates disclosure in the Acknowledgements (single-location rule). The §6 recommendation 3 names the bilateral reviewer-AI prohibition explicitly and reframes Disclosure 2.0 as a symmetric replacement, not as a one-sided ask. The equity dimension is now a named counter-argument in §5 plus a minimum viable manifest carve-out in §3, defined as items 1, 2, 3 and 6. The audit-log conflation (C7) is split into 5a/5b/5c. The distributional-reproducibility falsifier is operationalised at §5.

Three medium/low comments (C6 authorship-exclusion sentence, C10 AMEE Guide, C11 peer-reviewed ARS companion) the operator deferred or partially addressed. None are blockers; C6 is partially addressed via the explicit "No AI tool is listed as an author" sentence in Acknowledgements, and the other two are non-blocking suggestions that the operator may revisit on the editor's request.

One new internal inconsistency surfaced (see new comment N1 below): main.tex title-page declares 2,310 body words while the cover-letter table states 2,281. This is small but visible and should be reconciled by re-running `texcount` once and propagating the single number to both files.

My verdict is **`minor-revision`**. The acceptance criterion in my persona prompt — every previous-round blocker and high-severity comment resolved, no policy mis-quotation remains, implementability path concrete — is satisfied on the policy axis. The one remaining policy-relevant tightening (word-count reconciliation between manuscript and cover letter) is a desk-triage prevention, not a substantive objection.

---

## Round 1 comment status (verified file-by-file, not by trust)

### C1 — `blocker` — Policy-text mis-quotation — **closed**

§1 (line 89 of main.tex) now contains the verbatim phrasing: *"readability and language improvements only"* and the prohibited-uses sentence verbatim ("generate scientific arguments, draft methodology descriptions, write literature reviews, or create new content"). Image generation and reviewer-AI prohibition are placed in a separate sentence ("separate provisions prohibit AI-generated images and AI-assisted peer review, and place disclosure in the Acknowledgements"). The single-location Acknowledgements rule is honoured. `JOURNAL.md` §"Generative-AI disclosure policy" was updated in parallel to mirror the verbatim wording and to identify the reviewer-side prohibition as a separate Lancet provision. The reference entry `lancetaipolicy2024` carries the retrieval date 2026-05-20. Acceptable.

### C2 — `high` — Symmetry argument omits reviewer-AI prohibition — **closed**

§6 recommendation 3 (line 172) names the prohibition explicitly: *"The current Lancet policy prohibits reviewer-side AI use. Combined with author-side restrictions, the equilibrium is both-sides prohibited. Disclosure 2.0 proposes symmetric replacement: both author- and editor-side reviewer-AI are permitted, conditional on equivalent disclosure manifests."* The "wrong-direction symmetry" critique from R1 is met.

### C3 — `high` — Implementability / Editorial Manager — **closed**

§6 recommendation 1 (line 168) describes a concrete 90-day pilot path: Disclosure 2.0 PDF uploaded alongside the cover letter, the editorial office verifies the linked Zenodo DOI against the schema, 5–10 Lancet DH submissions per quarter would suffice. No Aries Systems / Editorial Manager feature work is required initially; a Crossref-style metadata extension is named as a natural follow-on. This is a credible pilot path an editorial board can evaluate.

### C4 — `high` — Equity dimension absent — **closed**

Two changes: (i) §3 (line 116) introduces the **minimum viable manifest** = items 1, 2, 3, 6 for low-resource submissions, with items 4 and 5 becoming required only when audit-subagent compute is available; (ii) §5 (line 160) carries an explicit "This proposal is for well-resourced submitters only" counter-argument that names git-fluency / Zenodo / public-tagged-release cost and identifies the present repository as a forkable MIT-licensed worked example. The reframing is honest about the residual asymmetry while reducing it.

### C5 — `high` — Self-undermining demonstration claim — **closed**

§5 (line 154) now reads: *"The first round of reviewer-subagent critique of this Viewpoint (transcripts at `reviewer-logs/viewpoint-round-01/`) caught three forward references to artefacts not yet committed (a re-execution check script, a JSON schema, and a ledger file). Disclosure 2.0 handles this by preserving the finding and recording resolution in the next commit, not silently fixing the manuscript."* I verified the claim against the Round 1 methodology-reviewer transcript (`reviewer-logs/viewpoint-round-01/methodology.md`) and the three artefacts: `docs/disclosure2-schema.json` (NEW, 5.5K), `docs/ledger.md` (NEW, 3.8K) and `scripts/regenerate_ledger.py` (NEW, 5.2K) are all present at HEAD. The §5 narrative is therefore empirically anchored. (`case-study/analysis/99_reexec_check.py` is still pending as a Layer-1 release-time artefact; the manuscript text honestly describes the downgrade behaviour if Layer 1 ships the release without it.) Resolved.

### C6 — `medium` — Authorship-exclusion reinforcement undersold — **partially closed**

The Acknowledgements now contains the explicit sentence *"No AI tool is listed as an author of this Viewpoint"*. The additional §6 sentence I suggested in R1 (making the visibility-as-reinforcement argument explicit) is not added. The current placement is acceptable; the response-to-reviewers correctly logs this as `◐` rather than `✓`. Not raised again.

### C7 — `medium` — Audit log conflation — **closed**

§3 item 5 (line 112) splits the audit log into 5a re-execution, 5b citation veracity (DOI + author list + journal + year + in-text claim-to-source alignment), and 5c headline-statistic rederivation, with the explicit note that "Partial discharge of (5a) alone does not satisfy item 5." The schema (`docs/disclosure2-schema.json`) mirrors this with the `audit.reExecution`, `audit.citationVeracity`, `audit.statisticalReproducibility`, `audit.claimDataAlignment`, `audit.consolidatedFindings` fields.

### C8 — `medium` — Reference-list placeholders — **mostly closed**

`repoprereg` SHA filled with `88d6d15`. The `<<HEADLINE:layer3_primary>>` macro is gone from §4; replaced with the conditional pre-written prose (line 144) carrying both branches (positive and null). `lintom2026` and `linehs2024` retain verification-on-submission notes in `references.bib`. These are operator-step items, not policy mis-statements; appropriate.

### C9 — `medium` — "Literal vs sympathetic" framing — **closed**

§1 (line 89) names the three harms explicitly with documented citations: authorship inflation (cites `icmje2024`), scientific hallucination (cites `luSakana2026` and `zhaoHallucinations2026`), and undocumented intervention. The "we read our own policy sympathetically" desk-editor objection is pre-empted.

### C10 — `low` — AMEE Guide and cross-journal comparator — **deferred (acceptable)**

Operator deferred citing the reference ceiling (currently 14/30, so there is headroom, but the operator's editorial judgement is that the manuscript is tighter without it). Non-blocking; not re-raised.

### C11 — `low` — ARS citation fragile — **deferred (acceptable)**

Comparator retained; peer-reviewed companion citation deferred. Non-blocking; not re-raised.

### C12 — `low` — Distributional reproducibility operationalisation — **closed**

§5 (line 150): *"re-running Layer 1 against the same model identifier, snapshot date and committed tool envelope must yield the same selected sub-claim and statistical method across three independent runs, with the headline effect size within the original's bootstrap 95% interval"* — meets the one-line operationalisation request.

---

## Newly identified Round 2 issues

### N1 — `low` — Word-count inconsistency between manuscript and cover letter

`main.tex` line 60 declares "Body word count. 2,310". `cover-letter.md` line 58 declares "2 281". The discrepancy (29 words) is small but visible to a desk editor who reads both. Re-run `texcount -inc -sum manuscript/main.tex` once and propagate the single number to both documents. The operator's annotation "operator-supplied; `texcount -inc -sum` at submission" already names this; the recommendation is to run the command now and reconcile, since the submission release is the natural lock point for word-count display.

### N2 — `low` — `references.bib` numerals carry verification-pending notes for two of fourteen entries

`lintom2026` and `linehs2024` retain placeholder notes. The Viewpoint cannot go for review with these unresolved at the live submission moment. The response-to-reviewers correctly logs them as operator-step items; flagged here only so the Round 2 record shows the policy reviewer noticed.

### N3 — `low` — `JOURNAL.md` Generative-AI disclosure section now contains an interpretive note ("the Disclosure 2.0 proposal lifts both prohibitions in favour of bilateral disclosure")

This is correct and consistent with §6 recommendation 3, but `JOURNAL.md` is the operator's working interpretation, not a manuscript. The interpretive sentence is appropriate in this file; flagged only so the operator confirms that this sentence does not propagate into the Editorial Manager submission metadata.

---

## Verdict

**`minor-revision`.**

The blocker (C1) and all four high-severity comments (C2, C3, C4, C5) are resolved on the policy axis and are verifiable in the repository at HEAD. The medium and low comments are either closed or appropriately deferred. The remaining policy-relevant tightening (N1, word-count reconciliation) is a one-command operator step.

If N1 is reconciled before submission and the operator-step items in the response-to-reviewers (medRxiv DOI, Zenodo DOI, Layer-1 `99_reexec_check.py` script at `case-study-v1.0.0`, suggested-reviewer details, live IFA re-verification on submission day) are completed at the release tag, the manuscript is policy-acceptable for desk triage. No further policy round is required.
